Investment Thesis
AVAI Bio exhibits severe financial distress with negative stockholders' equity of -$2.8M, indicating the company is technically insolvent. The company is burning cash at an unsustainable rate (-$959K operating cash flow) while generating minimal revenue ($276.3K) with negative gross margins, suggesting fundamental business model failure.
Strengths
- Minimal debt obligations provide some operational flexibility
- Early-stage company status may allow for strategic pivots
- Positive revenue generation exists despite losses
Risks
- Negative stockholders' equity indicates technical insolvency and imminent going concern issues
- Severe liquidity crisis with current ratio of 0.02x and only $50.4K cash against $3.0M liabilities
- Catastrophic unit economics with -$3.46 of cash burn for every $1 of revenue generated
- Negative gross margins indicate products/services are losing money at point of sale
- Unsustainable cash burn rate of -$959K with current cash reserves lasting approximately 2 weeks
Key Metrics to Watch
- Cash runway and path to profitability or capital raise
- Revenue growth trajectory and gross margin improvement
- Monthly cash burn rate and covenant compliance status
Financial Metrics
Revenue
276.3K
Net Income
-553.7K
EPS (Diluted)
$0.00
Free Cash Flow
-959.0K
Total Assets
172.9K
Cash
50.4K
Profitability Ratios
Gross Margin
-14.6%
Operating Margin
-540.8%
Net Margin
-200.4%
ROE
N/A
ROA
-320.2%
FCF Margin
-347.1%
Balance Sheet & Liquidity
Current Ratio
0.02x
Quick Ratio
-0.15x
Debt/Equity
N/A
Debt/Assets
1,716.1%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-20T10:44:10.270224 |
Data as of: 2025-12-31 |
Powered by Claude AI